a randomized , placebo controlled , double-blind cross-over study was conducted to evaluate the clinical efficacy of the anticholinergic agent , benztropine mesylate ( cogentinr ) in 29 patients with mild to moderate , idiopathic parkinson disease .
C0053156
benztropine
C0030567
idiopathic parkinson